Nina A. Netesova

Nina A. Netesova

Auto-generated profile, based on publicly available information

Nina A. Netesova

State Research Center for Virology and Biotechnology “Vector

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2014 in Journal of Molecular Recognition
Verified
Journal Article
Closed access
PDF file
BZBoris N. Zaitsev
Boris N. Zaitsev
FBFabrizio Benedetti
Fabrizio Benedetti
AMAndrey G. Mikhaylov
Andrey G. Mikhaylov
Denis KorneevDenis Korneev
Denis Korneev
SSSergey Sekatskii
Sergey Sekatskii
Valeriy B LoktevValeriy B Loktev
Valeriy B Loktev

20 September 2019
Verified
Journal Article
Closed access
NSNatalia Smetannikova
Natalia Smetannikova
AEA.A. Evdokimov
A.A. Evdokimov
NNN.A. Netesova
N.A. Netesova
MAM.A. Abdurashitov
M.A. Abdurashitov
AAA.G. Akishev
A.G. Akishev
SDS.Kh. Degtyarev
S.Kh. Degtyarev

6 May 2020 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
GIGeorgy M. Ignatyev
Georgy M. Ignatyev
AAAlena V. Atrasheuskaya
Alena V. Atrasheuskaya
LSLidiya L. Sukhanova
Lidiya L. Sukhanova
ЕСЕлена Серафимовна Сидоренко
Елена Серафимовна Сидоренко
НННина Александровна Нетесова
Нина Александровна Нетесова
ЛСЛидия Львовна Суханова
Лидия Львовна Суханова
Aim. To study the genetic stability of the measles virus strain Leningrad-16 (L-16) used for the production of vaccine at JSC NPO Mikrogen.Materials and methods. A series of production and sowing strains of L-16 (JSC NPO Mikrogen), ready-made series of measles vaccines from various manufacturers, and the strain of measles virus genotype D6 were studied. Molecular genetic study of the strains was performed using RT-PCR followed by restriction analysis and sequencing.Results. The complete genome sequences of the production and sowing strains of L-16 that are used for vaccine production were obtained. The sequence of the vaccine strain was deposited in GenBank. Strain L-16 was confirmed to be genetically stable. The obtained data demonstrated the possibility of using the RT-PCR method with subsequent restriction analysis to confirm the authenticity of the vaccine strain L-16 in finished mono and three component vaccines.Conclusion. The results of the study suggest the applicability of the molecular genetic methods to confirm the authenticity of the studied strains not only at the production stages, but also in the finished series of vaccines.

1 January 2002 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
NNN. A. Netesova
N. A. Netesova
LGL. N. Golikova
L. N. Golikova
LOL. G. Ovetchkina
L. G. Ovetchkina
AEA. A. Evdokimov
A. A. Evdokimov
EME. G. Malygin
E. G. Malygin
SDS. Kh. Degtyarev
S. Kh. Degtyarev

1 January 2016
Verified
Journal Article
Closed access
AEA A Evdokimov
A A Evdokimov
NNNina Netesova
Nina Netesova
NSN A Smetannikova
N A Smetannikova
MAM A Abdurashitov
M A Abdurashitov
AAA G Akishev
A G Akishev
SDS Kh Degtyarev
S Kh Degtyarev

26 June 2020 in Biological Products. Prevention, Diagnosis, Treatment
Verified
Journal Article
Open access
PDF file
GIG. M. Ignatyev
G. M. Ignatyev
AOA. S. Oksanich
A. S. Oksanich
LAL. P. Antonova
L. P. Antonova
TST. G. Samartseva
T. G. Samartseva
SMS. V. Mosolova
S. V. Mosolova
NNN. A. Netesova
N. A. Netesova
Rabies is an acute viral disease caused by a virus of the Rhabdoviridae family of the Lyssavirus genus, which affects the central nervous system and is characterised by absolute mortality. Vaccination is the only way to prevent the disease in humans. One of the products used for vaccination is a cultural concentrated purified inactivated dry rabies vaccine produced by the Federal State Budgetary Institution of Science “Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences” (hereinafter—Chumakov Center).The aim of the study was to examine the structure of the working virus seed of Vnukovo-32 strain used by the Chumakov Center for rabies vaccine production, to assess its genetic stability during production, to explore the possibility of using molecular genetic methods for identification of the production strain in the finished dosage form, and to study the nucleotide sequence of the CVS strain.Materials and methods: Vnukovo-32 rabies virus production strain, working virus seeds, finished batches of the rabies vaccine, CVS fixed rabies virus strain used in the assessment of specific immunity. The molecular genetic study was performed using RT-PCR followed by restriction and sequencing.Results: the paper presents the results of nucleotide sequence analysis of the G gene fragment obtained from the Vnukovo-32 production strain, batches of the working virus seed, and finished batches of the rabies vaccine produced in 2012, 2018, and 2019, and the CVS fixed rabies virus strain used in the assessment of the vaccine’s specific immunity. The study demonstrated that restriction analysis could be used for Vnukovo-32 strain identification at all production stages, including the finished dosage form.Conclusion: Vnukovo-32 and CVS strains used by the Chumakov Center are rabies viruses. Analysis of the nucleotide sequence of the G gene fragment showed that the Vnukovo-32 strain remains stable throughout different production stages. The obtained nucleotide sequence of gene G of the Vnukovo-32 strain was deposited in GenBank (accession number MN116503). The study demonstrated that restriction analysis could be used for Vnukovo-32 strain identification at all production stages, including the finished dosage form.